Federation des caisses Desjardins du Quebec’s 10x Genomics TXG Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-50	Closed	-$1.06K	–	3144
2026 Q1	$1.06K	Buy	+50	New	+$1K	﹤0.01%	2750
2025 Q3	–	Sell	-350	Closed	-$4.05K	–	2989
2025 Q2	$4.05K	Sell	350 -210	-38%	-$1.91K	﹤0.01%	2297
2025 Q1	$4.89K	Hold	560	–	–	﹤0.01%	2172
2024 Q4	$8.04K	Hold	560	–	–	﹤0.01%	1948
2024 Q3	$12.6K	Buy	+560	New	+$11.6K	﹤0.01%	1812
2022 Q2	–	Sell	-355	Closed	-$27K	–	2596
2022 Q1	$27K	Hold	355	–	–	﹤0.01%	1747
2021 Q4	$52.8K	Sell	355 -346	-49%	-$53K	﹤0.01%	1581
2021 Q3	$102K	Buy	701 +60	+9%	+$10.3K	﹤0.01%	1394
2021 Q2	$125K	Hold	641	–	–	﹤0.01%	1348
2021 Q1	$116K	Hold	641	–	–	﹤0.01%	1291
2020 Q4	$90.8K	Buy	+641	New	+$93K	﹤0.01%	1322

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's TXG Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec sold out of 10x Genomics (TXG) in Q2 2026, closing a stake of 50 shares — an estimated $1.06K sold.

Federation des caisses Desjardins du Quebec first reported a position in TXG in Q4 2020 and held it in 11 quarters. The position peaked at $125K in Q2 2021. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Federation des caisses Desjardins du Quebec reported no remaining 10x Genomics position as of Q2 2026 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 50 10x Genomics shares in Q2 2026, an estimated $1.06K.
Federation des caisses Desjardins du Quebec first reported a position in 10x Genomics in Q4 2020 and held it in 11 quarters.
Federation des caisses Desjardins du Quebec's 10x Genomics position peaked at $125K in Q2 2021.
390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.